Article Details

Nepal allows Chinese mRNA vaccine candidate to conduct Phase III clinical trials - Xinhua

Retrieved on: 2021-08-27 11:45:54

Tags for this article:

Click the tags to see associated articles and topics

Nepal allows Chinese mRNA vaccine candidate to conduct Phase III clinical trials - Xinhua. View article details on hiswai:

Excerpt

KATHMANDU, Aug. 27 (Xinhua) -- A messenger RNA (mRNA) COVID-19 vaccine candidate developed by Chinese manufacturers has gained approval from the Nepali ...

Article found on: www.news.cn

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up